|
MechanismHypoxia-inducible factor 1 modulators [+1] |
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Mitos Technologies, Inc.
0 Patents (Medical) associated with Mitos Technologies, Inc.
100 Deals associated with Mitos Technologies, Inc.
100 Translational Medicine associated with Mitos Technologies, Inc.